Oxcarbazepine
NDC Package 27241-306-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy). Marketed by Ajanta Pharma Usa Inc., this product is identified by NDC 27241-306 and is authorized under FDA application NDA202810.

Identification & Billing

NDC Package Code
27241-306-01
Package Description
100 TABLET, EXTENDED RELEASE in 1 BOTTLE
Product Code
27241-306
11-Digit Billing Format
27241030601
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk
  • RxCUI: 1365653 - OXcarbazepine 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1365653 - 24 HR oxcarbazepine 150 MG Extended Release Oral Tablet
  • RxCUI: 1365653 - oxcarbazepine 150 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 1365842 - OXcarbazepine 300 MG 24HR Extended Release Oral Tablet
  • RxCUI: 1365842 - 24 HR oxcarbazepine 300 MG Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Oxcarbazepine
Dosage Form
-
Usage Information
Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

Regulatory & Marketing

Labeler Name
Ajanta Pharma Usa Inc.
FDA Application #
NDA202810
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
08-09-2024
Listing Expiration
12-31-2025
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 27241-306-01 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Oxcarbazepine, labeled by Ajanta Pharma Usa Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Ajanta Pharma Usa Inc. on August 09, 2024. The current certification is valid through December 31, 2025.

What are the primary indications for this medication?

Oxcarbazepine is used alone or with other medications to treat seizure disorders (epilepsy).

How is this Ajanta Pharma Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 27241030601. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
27241-306-01
11-Digit CMS (5-4-2)
27241-0306-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.